Login / Signup

Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: A Danish nationwide cohort study.

Hans Christian RingJonathan ThorsenBrian KirbyJohn R IngramNana Aviaaja Lippert RosenøNikolaj HolgersenValdemar W NielsenDavid Nikolai Thein AagaardJulia-Tatjana MaulJashin J WuJacob P ThyssenAlexander EgebergSimon F Thomsen
Published in: The British journal of dermatology (2024)
Keyphrases
  • hidradenitis suppurativa
  • ankylosing spondylitis
  • ulcerative colitis
  • free survival
  • cross sectional
  • adverse drug
  • emergency department
  • rheumatoid arthritis